中國國貿(600007.SH):吳相仁接替唐煒擔任公司總經理職務
格隆匯5月29日丨中國國貿(600007.SH)公佈,公司七屆二十次董事會會議召開,會議以12票贊成、0票反對、0票棄權,同意自2020年5月29日起,吳相仁接替唐煒擔任公司總經理職務。
吳相仁,1965年出生,擁有工商管理碩士學位。歷任國辦祕書二局副處長、處長、副局長、正局級幹部。2016年4月,任商務部綜合司司長。2017年12月至2020年5月,任商務部辦公廳主任兼國際貿易談判代表祕書局局長、部新聞辦公室主任、新聞發言人。長期參與國家對外經濟貿易及港澳經濟政策的研究制定和執行工作。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.